The Messenger

The Messenger, authored by Peter Loftus, is an enthralling and timely exploration of the development and commercialization of the Moderna COVID-19 vaccine. This book provides a behind-the-scenes look at the groundbreaking scientific and business innovations that led to the development and successful deployment of the vaccine in record time.

Peter Loftus is a highly respected pharmaceutical and biotechnology journalist with over 20 years of experience covering the industry for The Wall Street Journal. He is known for his insightful reporting on the business, regulatory, and scientific aspects of the pharmaceutical and biotech industries.

The Messenger provides a comprehensive account of the development of the Moderna vaccine, from its inception in a research lab to its rapid deployment in the midst of a global pandemic. Loftus provides a detailed examination of the scientific innovations that made the vaccine possible, including the use of messenger RNA technology, which had never before been used in a vaccine.

In addition to its scientific innovations, The Messenger also explores the business and regulatory challenges that Moderna faced in bringing its vaccine to market. Loftus provides a detailed account of the company's strategy, including its decision to pursue a partnership with the US government and its use of innovative manufacturing and distribution strategies to ensure rapid deployment of the vaccine.

Overall, The Messenger is an essential read for anyone interested in the intersection of science, business, and public health. Loftus's insightful reporting and engaging writing style make this book an enthralling and informative account of one of the most important medical breakthroughs of our time.

Author: Peter Loftus

Link to buy: https://www.amazon.com/Messenger-Moderna-Vaccine-Business-Changed-ebook/dp/B099KP24ZW/

Ratings: 4.2 out of 5 stars (from 41 reviews)

Best Sellers Rank: #263,747 in Kindle Store

#16 in Pharmaceutical & Biotechnology Industry (Kindle Store)

#49 in Business Research & Development

#53 in Pharmaceutical & Biotechnology Industry (Books)